Cel-Sci (United States)
CEL-SCI Corporation | Cancer Immunotherapy Biotech (CVM)
CEL-SCI Corporation (NYSE American: CVM) develops Multikine and LEAPS immunotherapies that harness the immune system to treat cancer and other diseases involving cancer immunotherapy.
Company details
- Address
- Vienna, United States
- Website
- cel-sci.com
Reviews
No reviews yet.
Domain and WHOIS record
- Domain
- cel-sci.com
- Registrar
- Network Solutions, LLC
- Registered
- 3 Apr 1996
- Expires
- 4 Apr 2028
- Record updated
- 22 Jul 2025
- Name servers
- dns1.stabletransit.com, dns2.stabletransit.com
- DNSSEC
- Not signed